All In MedTech

Device Trial Radar · NCT00094536

Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System

A Study to Evaluate the Effectiveness of Extended Treatment Regimens With the Her Option® Cryoablation Therapy System for Treatment of Menorrhagia

Last checked: Nov 20, 2026Latest source record: Mar 3, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

82

Actual

Start

Apr 2004

Primary completion

Oct 2007

Study completion Jun 2009

Sponsor

Lead sponsor
CooperSurgical Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 21, 2004

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
Who can join
Female only, from 30 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Her Option® Cryoablation Therapy System is a closed-loop cryosurgical device that is used to ablate the endometrial lining in pre-menopausal women with menorrhagia (excessive menstrual bleeding) due to benign causes. This is a non-incisional procedure, which can be performed in a physicians office with minimal sedation. Initial FDA clinical studies were conducted with a two-freeze treatment pattern consisting of a 4 minute freeze with the Cryoprobe positioned in one cornu followed by a second freeze of 6 minutes with the Cryoprobe repositioned in the contralateral cornu. Since completion of the early studies, many physicians have experimented with varying freeze patterns using longer freeze durations and/or additional freezes at the fundus and the lower uterine segment. The results, as reported in the literature, indicate that these extended freeze patterns produce significantly better results than the original regimen.

Conditions

  • Menorrhagia

Interventions

  • Extended treatment regimen using Her Option CryotherapyDevice

    Extended treatment regimens using the Her Option Endometrial Cryotherapy System to more effectively ablate the endometrial lining, reducing menstrual levels to normal or less.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Success (Reduction in Menstruation to Normal Levels)Time frame: 1 Year

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Kelly Roy, M.D., P.C.

    Phoenix, Arizona

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.